Company NeuroScientific Biopharmaceuticals Limited
Equities
NSB
AU0000012973
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 AUD | 0.00% | -4.26% | +2.27% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Simon Scott
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-31 |
Dougal Thring
COO | Chief Operating Officer | - | 21-03-30 |
Anton Uvarov
BRD | Director/Board Member | - | 17-09-28 |
- | - | ||
Corporate Secretary | - | 02-05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anton Uvarov
BRD | Director/Board Member | - | 17-09-28 |
Chairman | - | 11-16 | |
Tony Keating
BRD | Director/Board Member | - | 12-04 |
Clarke Barlow
BRD | Director/Board Member | 43 | 11-16 |
Linda Friedland
BRD | Director/Board Member | - | 23-10-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 144,604,870 | 94,222,747 ( 65.16 %) | 0 | 65.16 % |
Company contact information
Neuroscientific Biopharmaceuticals Ltd.
85 Forrest Street Suite 5
6011, Cottesloe
+61 8 6382 1805
http://www.neuroscientific.comSector
1st Jan change | Capi. | |
---|---|---|
+2.27% | 4.31M | |
+28.89% | 49.18B | |
+1.27% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.78% | 26.09B | |
-22.16% | 18.71B | |
+7.89% | 13.26B | |
+32.27% | 12.32B | |
-0.43% | 11.99B |
- Stock Market
- Equities
- NSB Stock
- Company NeuroScientific Biopharmaceuticals Limited